Status: current, Defined. Date: 30-Jun 2022. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
5067456010 | Product containing precisely fosaprepitant (as fosaprepitant dimeglumine) 115 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
5067457018 | Fosaprepitant (as fosaprepitant dimeglumine) 115 mg powder for solution for infusion and/or injection vial | en | Synonym | Active | Case insensitive | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Fosaprepitant (as fosaprepitant dimeglumine) 115 mg powder for solution for infusion and/or injection vial | Is a | Fosaprepitant only product in parenteral dose form | true | Inferred relationship | Some | ||
Fosaprepitant (as fosaprepitant dimeglumine) 115 mg powder for solution for infusion and/or injection vial | Has manufactured dose form | Powder for solution for infusion and/or injection | true | Inferred relationship | Some | ||
Fosaprepitant (as fosaprepitant dimeglumine) 115 mg powder for solution for infusion and/or injection vial | Has unit of presentation | Vial | true | Inferred relationship | Some | ||
Fosaprepitant (as fosaprepitant dimeglumine) 115 mg powder for solution for infusion and/or injection vial | Plays role | Antiemetic therapeutic role | true | Inferred relationship | Some | ||
Fosaprepitant (as fosaprepitant dimeglumine) 115 mg powder for solution for infusion and/or injection vial | Has precise active ingredient | Fosaprepitant dimeglumine | true | Inferred relationship | Some | 1 | |
Fosaprepitant (as fosaprepitant dimeglumine) 115 mg powder for solution for infusion and/or injection vial | Has BoSS | Fosaprepitant | true | Inferred relationship | Some | 1 | |
Fosaprepitant (as fosaprepitant dimeglumine) 115 mg powder for solution for infusion and/or injection vial | Has presentation strength numerator unit | mg | true | Inferred relationship | Some | 1 | |
Fosaprepitant (as fosaprepitant dimeglumine) 115 mg powder for solution for infusion and/or injection vial | Has presentation strength denominator unit | Vial | true | Inferred relationship | Some | 1 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Fosaprepitant (as fosaprepitant dimeglumine) 115 mg powder for solution for infusion vial | Is a | True | Fosaprepitant (as fosaprepitant dimeglumine) 115 mg powder for solution for infusion and/or injection vial | Inferred relationship | Some | |
Fosaprepitant (as fosaprepitant dimeglumine) 115 mg powder for solution for injection vial | Is a | True | Fosaprepitant (as fosaprepitant dimeglumine) 115 mg powder for solution for infusion and/or injection vial | Inferred relationship | Some |
This concept is not in any reference sets